West Pharmaceutical Services (WST) Tax Provisions (2009 - 2026)

West Pharmaceutical Services has disclosed Tax Provisions across 18 years of filings, most recently posting $32.2 million for Q2 2026.

• In Q2 2026, Tax Provisions rose 6.62% year-over-year to $32.2 million; the TTM figure through Jun 2026 stood at $144.2 million (up 16.76% YoY), while the FY2025 annual figure was $121.6 million, up 13.12% from the prior year.
• Tax Provisions came in at $32.2 million for Q2 2026 at West Pharmaceutical Services, down from $44.7 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $44.7 million in Q1 2026 to a low of $16.4 million in Q1 2024.
• Average Tax Provisions over 5 years is $30.2 million, with a median of $31.2 million recorded in 2025.
• Year-over-year, Tax Provisions sank 37.07% in 2024 and soared 85.48% in 2026.
• Over 5 years, Tax Provisions stood at $28.9 million in 2022, then increased by 19.38% to $34.5 million in 2023, then rose by 6.67% to $36.8 million in 2024, then dropped by 9.51% to $33.3 million in 2025, then declined by 3.3% to $32.2 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $32.2 million in Q2 2026, $44.7 million in Q1 2026, and $33.3 million in Q4 2025.